Vitamin K2 Bone Health Randomized Trial: What the Evidence Says

Quick Answer

Vitamin K2 Bone Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease. [D’Elia Saverio (2025); evidence level 3]
• Epidemiological studies further indicate that populations in regions with higher sun exposure exhibit lower prevalence of deficiency and reduced mortality from chronic disease. [D’Elia Saverio (2025); evidence level 3]
• Epidemiological studies support this notion, reporting that higher vitamin K status is associated with better physical performance and lower risk of mobility limitation in older adults. [Ran Xiaoyu (2026); evidence level 4]
• Phylloquinone is abundant in green leafy vegetables such as spinach, kale, and broccoli, whereas menaquinones are synthesized by bacterial fermentation and found in foods such as natto, cheese, dairy, and meat products. [Ran Xiaoyu (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For vitamin K2 bone health randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• D’Elia Saverio (2025). Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties. DOI: 10.3390/ijms27010298. PMCID: PMC12785717. PMID: 41516172. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12785717/
• Ran Xiaoyu (2026). Vitamin K and muscle health: mechanisms and clinical perspectives in sarcopenia and beyond: narrative review. DOI: 10.3389/fnut.2026.1726483. PMCID: PMC12979126. PMID: 41835384. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12979126/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.